UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000033945
Receipt No. R000038680
Scientific Title Examination of the usefulness of the musculoskeltal ultrasonography on hyperuricemia in children
Date of disclosure of the study information 2018/08/30
Last modified on 2018/08/29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Examination of the usefulness of the musculoskeltal ultrasonography on hyperuricemia in children
Acronym Examination of the usefulness of the musculoskeltal ultrasonography on hyperuricemia in children
Scientific Title Examination of the usefulness of the musculoskeltal ultrasonography on hyperuricemia in children
Scientific Title:Acronym Examination of the usefulness of the musculoskeltal ultrasonography on hyperuricemia in children
Region
Japan

Condition
Condition Hyperuricemia in children
Classification by specialty
Pediatrics
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 the usefulness of the musculoskeletal ultrasonography
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes An uric acid sodium salt (MUS) crystal is composed and aims at the structure obstacle such as inflammatory views and the consequent quality of bone and skin change and soft tissue obstacle for the evaluation.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Cluster
Blinding Double blind -all involved are blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Diagnosis
Type of intervention
Maneuver
Interventions/Control_1 Musculoskeletal ultrasonography
Interventions/Control_2 one time
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
5 years-old <=
Age-upper limit
15 years-old >=
Gender Male and Female
Key inclusion criteria Hyperuricemia in children
Key exclusion criteria The affected child whom the affected child with the lesion except an injury and the gout, a mental condition judged to supersonic wave enforcement joint if the study person in charge including the patient that an affected child thought to be the intolerance, a family or the person refused inspection for inspection or a study cooperator was inappropriate as a subject.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name MATSUDA TAKUYA
Organization Oosaka Medical Univ. Sch. of Med.
Division name Pediatric
Zip code
Address 2-7 Daigaku, Takatsuki-shi, Oosaka
TEL 072-683-1221
Email takuya96matsuda@yahoo.co.jp

Public contact
Name of contact person
1st name
Middle name
Last name MATSUDA TAKUYA
Organization Oosaka Medical Univ. Sch. of Med.
Division name Pediatric
Zip code
Address 2-7 Daigaku, Takatsuki-shi, Oosaka
TEL 072-683-1221
Homepage URL
Email takuya96matsuda@yahoo.co.jp

Sponsor
Institute Dept. of Pediatr., Oosaka Medical Univ. Sch. of Med.
Institute
Department

Funding Source
Organization Dept. of Pediatr., Oosaka Medical Univ. Sch. of Med.
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 08 Month 30 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2018 Year 07 Month 17 Day
Date of IRB
Anticipated trial start date
2018 Year 07 Month 17 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2018 Year 08 Month 29 Day
Last modified on
2018 Year 08 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038680

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.